Frontlight ResearchEarly access
Trial site
US Oncology Investigational Products Center (IPC)
- 12running trials
- 2closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Colorectal cancer2 trials
- Kidney cancer2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Liver and biliary tract cancer1 trial
- Metastatic breast cancer1 trial
- Phase
- Phase 37 trials
- Phase 1/23 trials
- Phase 22 trials
- Phase 2/32 trials
- Status
- Recruiting9 trials
- Active, not recruiting3 trials
- Completed2 trials
- Lead sponsor
- Pfizer10 trials
- Seagen, a wholly owned subsidiary of Pfizer3 trials
- Revolution Medicines, Inc.1 trial
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Active, not recruiting
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Bladder cancer1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Kidney cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026